KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Novavax (NVAX) Return on Assets (2016 - 2025)

Historic Return on Assets for Novavax (NVAX) over the last 17 years, with Q3 2025 value amounting to 0.27%.

  • Novavax's Return on Assets rose 4300.0% to 0.27% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.27%, marking a year-over-year increase of 4300.0%. This contributed to the annual value of 0.11% for FY2024, which is 1600.0% up from last year.
  • According to the latest figures from Q3 2025, Novavax's Return on Assets is 0.27%, which was up 4300.0% from 0.32% recorded in Q2 2025.
  • Over the past 5 years, Novavax's Return on Assets peaked at 0.34% during Q1 2025, and registered a low of 0.68% during Q4 2021.
  • In the last 5 years, Novavax's Return on Assets had a median value of 0.32% in 2023 and averaged 0.26%.
  • As far as peak fluctuations go, Novavax's Return on Assets plummeted by -3500bps in 2021, and later skyrocketed by 5900bps in 2025.
  • Quarter analysis of 5 years shows Novavax's Return on Assets stood at 0.68% in 2021, then skyrocketed by 57bps to 0.29% in 2022, then decreased by -9bps to 0.32% in 2023, then soared by 64bps to 0.11% in 2024, then skyrocketed by 337bps to 0.27% in 2025.
  • Its last three reported values are 0.27% in Q3 2025, 0.32% for Q2 2025, and 0.34% during Q1 2025.